Neogenomics (NEO) Earnings Date
The next earnings date for Neogenomics (NEO) is expected by Feb 22, 2027, per the data provider's calendar.
- Next earnings date
- Feb 22, 2027
- expected by · quarter ending Dec '26
- Consensus EPS
- $0.07
- Dec '26 quarter · 7 analysts
- Consensus revenue
- $210.6M
- Dec '26 quarter · 7 analysts
- Latest stored quarter
- EPS −0.06
- revenue $209.3M · reported Oct 28, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
Estimate-vs-actual scoring began Jul 2026, the Feb 22, 2027 report is the first we'll score. Earlier quarters predate our snapshots, so their surprise stays "—". We never backfill an estimate we didn't observe.
| Report | Est EPS | Act EPS | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|
| Oct 28, 20268-K, after close · 4:05 pm ET | 0.06 | −0.06 | $206.7M | $209.3M | +1.2% | −0.3%next session |
| Jul 28, 20268-K, after close · 4:05 pm ET | 0.03 | 0.02 | $196.9M | $201.7M | +2.4% | +14.0%next session |
| Apr 28, 20268-K, after close · 4:59 pm ET | — | −0.13 | — | $186.7M | — | −0.7%next session |
| Jan 12, 20268-K, before open · 7:10 am ET | — | −0.08c | — | $190.2M | — | −5.1%release day |
| Oct 28, 20258-K, before open · 7:09 am ET | — | −0.21 | — | $187.8M | — | −2.4%release day |
| Jul 29, 20258-K, before open · 7:08 am ET | — | −0.35 | — | $181.3M | — | −18.7%release day |
| Apr 29, 20258-K, before open · 7:35 am ET | — | −0.20 | — | $168.0M | — | −34.0%release day |
| Feb 18, 20258-K, before open · 7:08 am ET | — | −0.12c | — | $172.0M | — | −14.0%release day |
c Computed by Tenet. The company's diluted figure is not in our data feed for this period, so this is net income attributable to common shareholders divided by the larger of the weighted basic and diluted share counts.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 7 | 6 | 6 | 7 |
| Avg estimate | 0.07 | 0.05 | 0.20 | 0.31 |
| Low estimate | 0.07 | 0.04 | 0.19 | 0.30 |
| High estimate | 0.07 | 0.06 | 0.21 | 0.33 |
| Year-ago EPS | −0.08 | −0.13 | −0.84 | 0.20E |
| Implied growth | — | — | — | +53.4% |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 7 | 6 | 8 | 9 |
| Avg estimate | $210.6M | $206.0M | $808.2M | $888.0M |
| Low estimate | $210.0M | $205.1M | $807.6M | $882.6M |
| High estimate | $211.0M | $206.8M | $808.6M | $890.9M |
| Year-ago revenue | $190.2M | $186.7M | $727.3M | $808.2ME |
| Implied growth | +10.7% | +10.3% | +11.1% | +9.9% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | 0.07 | 0.05 | 0.20 | 0.31 |
| 7 days ago | 0.07 | — | 0.20 | 0.31 |
| 30 days ago | 0.07 | — | 0.19 | 0.34 |
| 60 days ago | 0.07 | — | 0.18 | 0.34 |
| 90 days ago | 0.07 | — | 0.18 | 0.34 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $0.07 → $0.07 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Neogenomics report earnings next?
Neogenomics' next earnings date is expected by Feb 22, 2027, per the data provider's calendar.
What were Neogenomics' latest quarterly earnings?
Neogenomics reported diluted EPS of −0.06 and revenue of $209.3M on Oct 28, 2026.
How did Neogenomics' stock move after its last earnings report?
Neogenomics moved −0.3% in the session after its Oct 28, 2026 report.

